A phase 1b study evaluating the safety and pharmacokinetics of regorafenib in combination with cetuximab in patients with advanced solid tumors

Overview of attention for article published in International Journal of Cancer, June 2019

Altmetric Badge

Mentioned by

twitter: 1 X user

Readers on

mendeley: 40 Mendeley

So far, Altmetric has seen 1 X post from an account with 983 followers.

A phase 1b study evaluating the safety and pharmacokinetics of regorafenib in combination with cetuximab in patients with advanced solid tumors. - PubMed - NCBI https://t.co/3G9mB6mprd

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.